CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,492 | -95.7% | 11,205 | -95.4% | 0.00% | -100.0% |
| Q2 2023 | $9,315,502 | +1960.8% | 244,309 | +2378.5% | 0.00% | – |
| Q4 2022 | $452,042 | -18.7% | 9,857 | -4.7% | 0.00% | – |
| Q3 2022 | $556,000 | +23.3% | 10,340 | +9.7% | 0.00% | – |
| Q2 2022 | $451,000 | -52.0% | 9,429 | -61.8% | 0.00% | – |
| Q1 2022 | $940,000 | -15.8% | 24,711 | +1.9% | 0.00% | -100.0% |
| Q4 2021 | $1,117,000 | +10.6% | 24,255 | -17.8% | 0.00% | – |
| Q3 2021 | $1,010,000 | +68.9% | 29,508 | +11.9% | 0.00% | – |
| Q2 2021 | $598,000 | +15.4% | 26,367 | +23.4% | 0.00% | – |
| Q1 2021 | $518,000 | +40.4% | 21,364 | +15.9% | 0.00% | – |
| Q4 2020 | $369,000 | +115.8% | 18,439 | +206.6% | 0.00% | – |
| Q3 2020 | $171,000 | -5.5% | 6,014 | -13.5% | 0.00% | – |
| Q2 2020 | $181,000 | +1192.9% | 6,954 | +468.1% | 0.00% | – |
| Q1 2020 | $14,000 | -83.3% | 1,224 | -84.5% | 0.00% | – |
| Q4 2019 | $84,000 | -10.6% | 7,912 | -3.6% | 0.00% | – |
| Q3 2019 | $94,000 | +4.4% | 8,204 | +3.2% | 0.00% | – |
| Q2 2019 | $90,000 | +233.3% | 7,949 | +139.4% | 0.00% | – |
| Q1 2019 | $27,000 | +170.0% | 3,321 | +109.5% | 0.00% | – |
| Q4 2018 | $10,000 | -16.7% | 1,585 | +26.4% | 0.00% | – |
| Q3 2018 | $12,000 | +9.1% | 1,254 | -0.8% | 0.00% | – |
| Q2 2018 | $11,000 | +57.1% | 1,264 | +34.9% | 0.00% | – |
| Q1 2018 | $7,000 | -12.5% | 937 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | -99.4% | 937 | -99.0% | 0.00% | -100.0% |
| Q3 2017 | $1,398,000 | +390.5% | 96,374 | +309.5% | 0.00% | – |
| Q2 2017 | $285,000 | +85.1% | 23,535 | +96.0% | 0.00% | – |
| Q1 2017 | $154,000 | +5.5% | 12,008 | -1.3% | 0.00% | – |
| Q4 2016 | $146,000 | +57.0% | 12,171 | +20.8% | 0.00% | – |
| Q3 2016 | $93,000 | -26.2% | 10,073 | -24.3% | 0.00% | – |
| Q2 2016 | $126,000 | +7.7% | 13,300 | -20.2% | 0.00% | – |
| Q1 2016 | $117,000 | -32.8% | 16,657 | 0.0% | 0.00% | – |
| Q4 2015 | $174,000 | +100.0% | 16,657 | +27.9% | 0.00% | – |
| Q3 2015 | $87,000 | -86.4% | 13,021 | -90.3% | 0.00% | -100.0% |
| Q2 2014 | $640,000 | +118.4% | 133,790 | +246.6% | 0.00% | – |
| Q3 2013 | $293,000 | – | 38,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |